Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage
NCT03213392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2017-09-19
Summary
General anesthetic induced neurotoxicity has received considerable attention in the past decade from various pre-clinical studies in rodents and non-human primates. Which demonstrated that exposure to general anesthetic agents for a longer duration can induce neuronal cell death that can lead to adverse neurodevelopmental outcomes.
The neuroapoptosis and impairment of neurodevelopmental processes has been postulated as the underlying mechanism, but the molecular mechanisms was not completely understood. Various hypothesis has been proposed they are- Antagonistic effect on N-methyl-D-aspartate receptors and agonistic effect on gamma-aminobutyric acid type A receptors; mitochondrial perturbations and activation of reactive oxygen species and dysregulation of intracellular calcium homeostasis. They trigger neuroapoptosis and cell death through the activation of caspases.3 Caspases, a group of cysteine proteases, plays an important role in regulation and execution of apoptosis. Caspase-3 is most important since it is activated by many cell death signals and cleaves a variety of important cellular proteins.4 Various anesthetic agents like isoflurane, halothane, sevoflurane, nitrous oxide and propofol causes neurotoxicity by activation of caspase-3. Which has been proven from various animal studies western blot analysis, immunohistochemical analysis and flow cytometric analysis.3, 5-9 Though it is documented that exposure to general anesthetics causes neurotoxicity during active brain growth in animals, there is no evidence of such effects in adult humans.10 and it is difficult to separate the effects of anesthetics from surgical impact and other factors associated with diseases.11 The patients with aneurysmal subarachnoid hemorrhage (SAH) have variable degree of neurological insults and it is possible, based on the evidence from animal models that administration of general anesthetics could add to the neuronal insults.
Conditions
Interventions
- DRUG
-
Anesthetic Agents
four different anesthetic agents will be used during the surgical clipping or coiling of the aneurysm for the maintenance of anesthesia.
Sponsors & Collaborators
-
Mukilan Balu
lead OTHER
Principal Investigators
-
MUKILAN BALASUBRAMANIAN, MD · PGIMER, chandigarh
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-01
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
- FDA Drug
- Yes
Countries
- India
Study Locations
More Related Trials
-
Searching a Dysfunction of Corticotropic & Thyrotropin Axis During the Acute Phase of a Subarachnoid Hemorrhage Secondary to Spontaneous Rupture of Cerebral Aneurysm
NCT03655509 ·Status: UNKNOWN ·Phase: NA
-
Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10
NCT05648526 ·Status: COMPLETED ·Phase: NA
-
Aneurysms and Carotid Artery Block in Newborns
NCT00646672 ·Status: COMPLETED
-
The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage
NCT04135456 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury
NCT01212679 ·Status: COMPLETED ·Phase: PHASE2
-
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
NCT00593242 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Relationship Between Inflammatory and Coagulation in SAH CSF
NCT04938414 ·Status: COMPLETED
-
Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage
NCT03209830 ·Status: COMPLETED ·Phase: PHASE2
-
Traumatic Brain Injury and the Gut Microbiome
NCT04949607 ·Status: COMPLETED ·Phase: NA
-
Impact of Mode of Anesthesia on Ischemia Modified Albumin in Patients With Traumatic Brain Injury
NCT04490122 ·Status: UNKNOWN
-
Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous Thrombosis
NCT03033966 ·Status: COMPLETED
-
Field Randomization of Nerinetide (NA-1) Therapy in Early Responders
NCT02315443 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Mannitol Volume with Changes in Osmolarity in Traumatic Brain Injury
NCT06846307 ·Status: COMPLETED ·Phase: PHASE3
-
Spreading Depolarization and Ketamine Suppression
NCT02501941 ·Status: COMPLETED ·Phase: PHASE1
-
Whole Body Cooling Using Phase Changing Material
NCT01138176 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Chronic Subdural Hematoma by Corticosteroids
NCT02650609 ·Status: COMPLETED ·Phase: PHASE3
-
Degradation of the Glycocalyx in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
NCT03706768 ·Status: UNKNOWN ·Phase: NA
-
Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion
NCT03952208 ·Status: COMPLETED ·Phase: NA
-
Chronic Subdural Hematoma and Aspirin
NCT03120182 ·Status: COMPLETED ·Phase: NA
-
The Application of Ketamine for Sedation in Patients With Cardiac Arrest - - KetCat (KETamine in Cardiac ArresT) Study
NCT04360070 ·Status: UNKNOWN ·Phase: NA
-
Establishment of a Predictive Model for Post-dural Puncture Headache
NCT06800859 ·Status: ENROLLING_BY_INVITATION
-
Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension
NCT07305922 ·Status: RECRUITING
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
NCT06582810 ·Status: RECRUITING
-
Vitamin B12 vs B3 for Nerve Regeneration and Functional Recovery After Pediatric Traumatic Brain Injury
NCT05958277 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine Infusion in Neurologic Deficit
NCT02636218 ·Status: COMPLETED ·Phase: PHASE2/PHASE3